Category Archives: Systematic Review/Meta-analysis of Ginkgo Use in Cognitive Impairment and Dementia

Systematic Review/Meta-analysis of Ginkgo Use in Cognitive Impairment and Dementia

EGb 761® (Dr. Willmar Schwabe GmbH & Co. KG; Karlsruhe, Germany) is a standardized ginkgo (Ginkgo biloba, Ginkgoaceae) leaf extract. It contains 22-27% flavonol glycosides, 5-7% terpene lactones, and < 5 ppm ginkgolic acids. Studies indicate that EGb 761 may be especially beneficial to patients with dementia plus neuropsychiatric symptoms (NPS). Hence, the objective of this systematic review and meta-analysis was

Read more